KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Income from Continuing Operations: 2009-2024

Historic Income from Continuing Operations for Emergent BioSolutions (EBS) over the last 16 years, with Dec 2024 value amounting to -$190.6 million.

  • Emergent BioSolutions' Income from Continuing Operations fell 55.40% to $51.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $75.9 million, marking a year-over-year increase of 136.35%. This contributed to the annual value of -$190.6 million for FY2024, which is 74.94% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Income from Continuing Operations of -$190.6 million as of FY2024, which was up 74.94% from -$760.5 million recorded in FY2023.
  • Emergent BioSolutions' Income from Continuing Operations' 5-year high stood at $305.8 million during FY2020, with a 5-year trough of -$760.5 million in FY2023.
  • For the 3-year period, Emergent BioSolutions' Income from Continuing Operations averaged around -$387.6 million, with its median value being -$211.6 million (2022).
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first soared by 461.10% in 2020, then tumbled by 259.40% in 2023.
  • Emergent BioSolutions' Income from Continuing Operations (Yearly) stood at $305.8 million in 2020, then declined by 28.22% to $219.5 million in 2021, then plummeted by 196.40% to -$211.6 million in 2022, then slumped by 259.40% to -$760.5 million in 2023, then soared by 74.94% to -$190.6 million in 2024.